NCT06682728 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06682728
Title	Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	University of California, Irvine
Indications	bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma invasive bladder transitional cell carcinoma
Therapies	Nivolumab + Sacituzumab govitecan-hziy
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Chao Family Comprehensive Cancer Center, University of California, Irvine	RECRUITING	Orange	California	92868	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06682728Clinical Trial Detail